Analysed VIVOS THERAPEUTICS INC (VVOS:NASDAQ) News Sources
New to The Street Broadcasts on Bloomberg Television at 6:30 PM EST Featuring IGC Pharma (IGC), Vivos Therapeutics (VVOS), Acurx Pharmaceuticals (ACXP), and Equinox Gold (EQX)
11-04-2026
yahoo.com
New to The Street to Broadcast on Fox Business on Monday, April 13, Featuring Virtuix Holdings (NASDAQ:VTIX), Medicus Pharma (NASDAQ:MDCX), YY Group Holdings (NASDAQ:YYGH), Vivos Therapeutics (NASDAQ:VVOS), and Stardust Power (NASDAQ:SDST)
11-04-2026
yahoo.com
Vivos Therapeutics Schedules Release of Full Year 2025 Financial Results and Conference Call
15-04-2026
yahoo.com
Vivos Therapeutics Inc (VVOS) Q4 2025 Earnings Call Highlights: Revenue Growth Amid Strategic ...
16-04-2026
yahoo.com
New to The Street to Broadcast Tonight on Bloomberg at 6:30 PM EST - Show #744 Featuring Virtuix Holdings (NASDAQ:VTIX), Neonc Technologies Holdings (NASDAQ:NTHI), Medicus Pharma (NASDAQ:MDCX), YY Group Holding (NASDAQ:YYGH), and Vivos Therapeutics (NASDAQ:VVOS)
18-04-2026
yahoo.com
Vivos Therapeutics Reports First Quarter 2026 Financial Results and Provides Operational Update
20-05-2026
yahoo.com
What is the current price of VIVOS THERAPEUTICS INC (VVOS:NASDAQ)?
The current price of VIVOS THERAPEUTICS INC (VVOS:NASDAQ) is $0.7222.
VIVOS THERAPEUTICS INC (VVOS:NASDAQ) absolute price change since previous trading day?
The absolute price change of VIVOS THERAPEUTICS INC (VVOS:NASDAQ) since the previous trading day is $0.0222.
VIVOS THERAPEUTICS INC (VVOS:NASDAQ) percentage price change since previous trading day?
The percentage price change of VIVOS THERAPEUTICS INC (VVOS:NASDAQ) since the previous trading day is 3.1714%.
What is the most recent average sentiment score for VIVOS THERAPEUTICS INC (VVOS:NASDAQ)?
The most recent average sentiment score for VIVOS THERAPEUTICS INC (VVOS:NASDAQ) is 68 out of 100.
What is the most recent average sentiment for VIVOS THERAPEUTICS INC (VVOS:NASDAQ)?
The most recent sentiment for VIVOS THERAPEUTICS INC (VVOS:NASDAQ) is .
SEC-8K** Filing Available For VIVOS THERAPEUTICS INC (VVOS:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.